Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology.
HLA-G is a nonclassical MHC class I molecule with restricted normal tissue distribution, but whose expression is induced in pathologic situations such as cancer. In regard to the its immunosuppressive properties, it has been suggested that HLA-G could be a way for tumors to escape immunosurveillance. HLA-G has been described in almost all types of cancer, whatever their origins. Ovarian cancer is the second leading cause of death among women with gynecologic cancers, after breast cancer. The high mortality rate of this pathology is linked to its late discovery resulting from discreet symptomatology at early stages and the current paucity of highly sensitive and specific biomarkers. The aim of the present study was to analyze, in a French, retrospectively based study, whether HLA-G could be a marker for the detection of ovarian cancer and the prediction of clinical evolution. For this purpose, we looked for HLA-G expression in ovarian carcinoma lesions from low to high grade and stage, and we showed that HLA-G is selectively expressed in advanced-stage disease of high-grade histology.
Menier
Catherine
C
CEA, I2 BM, Service de Recherches en Hemato-Immunologie, Paris, France. Catherine.Menier@cea.fr
Prevot
Sophie
S
Carosella
Edgardo D
ED
Rouas-Freiss
Nathalie
N
D018262:Adenocarcinoma, Clear Cell / Q000276:immunology / Q000473:pathology*; D005260:Female; D006680:HLA Antigens / Q000096:biosynthesis*; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000096:biosynthesis*; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000276:immunology / Q000473:pathology*; D010053:Ovary / Q000276:immunology / Q000473:pathology*; D012189:Retrospective Studies
D006680:HLA Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I